Dr. Khalil Sultanem, Chief of the Division of Radiation Oncology, with the new linear accelerator during the final stage of its installation. (Click on the photo to enlarge it.)
February 2023News

New linear accelerator goes into service in Radiation Oncology

Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.

READ MORE →
Dr. Claudia Kleinman
January 2023Research at the Lady Davis Institute

Researchers inch closer to better understanding of brain tumours in children

Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.

READ MORE →
Dr. Solon Schur
MilestonesSeptember 2022

Dr. Solon Schur joins JGH as skull base neurosurgical oncologist

Dr. Solon Schur has joined the JGH Division of Neurosurgery as a member of staff and as Assistant Professor of Neurosurgery.

READ MORE →
During a tour of a newly inaugurated JGH lab where clinical trials will be held for a promising cancer treatment, Pierre Fitzgibbon (second from right), Minister of Economy and Innovation, is briefed about the technology by Michel Gareau (right), Founder and President of Starpax Medical, and by Dr. Gerald Batist, Director of the Segal Cancer Centre. (Click this or any photo to enlarge it.)
June 2022News

New JGH lab launched to test potentially revolutionary cancer treatment

A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.

READ MORE →
Dr. Khalil Sultanem, Acting Chief of Radiation Oncology, with one of his Division’s linear accelerators. (Click on this or any photo to enlarge it.)
August 2021News

Major construction to install new cancer-fighting linear accelerator in Radiation Oncology

Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.

READ MORE →
Dr. April Rose
May 2021Milestones

Dr. April Rose joins Division of Medical Oncology

Dr. April Rose has joined the JGH as Attending Staff in the Division of Medical Oncology and in the Segal Cancer Centre.

READ MORE →
Dr. Michael Pollak (second from left) attends the launch of the Metastatic Breast Cancer Dream Team with (from left) co-leader Dr. Nahum Sonenberg; Marc Miller, Parliamentary Secretary for Crown-Indigenous Relations; and Suzanne Fortier, Principal of McGill University.
August 2019Research at the Lady Davis Institute

Dr. Michael Pollak to co-lead Metastatic Breast Cancer Dream Team

Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.

READ MORE →
A pelvic cancer patient undergoes single-site incision surgery, with the instruments of a surgical robot inserted through a special device and into a one-inch incision in the navel.
March 2018Spotlight feature

JGH leads Canada in performing advanced robotic surgery for gynecologic cancer

The JGH has become the first hospital in Canada to perform an advanced type of robotic surgery for gynecologic cancer, in which all of the medical instruments are inserted into the abdomen via a single, tiny incision in the navel.

READ MORE →
Dr. Sarit Assouline
May 2017Research at the Lady Davis Institute

Promising therapy for relapsed patients with aggressive form of lymphoma

A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.

READ MORE →
Dr. Gerald Batist
May 2017Research at the Lady Davis Institute

Segal Cancer Centre joins the “Cancer Moonshot”

The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.

READ MORE →